Lixte Biotech Holdings (LIXT) Stock Highlights

1.49 | -2.61%

2024-11-21 06:39:30

Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which therapies are urgently needed. It mainly designs drugs for which there are existing data suggesting any effect on altered pathways of the cancer cell and may be given safely to humans. The development program of the company includes drugs for the treatment of cancer, consisting of protein phosphatase inhibitors and histone deacetylase inhibitors.

Statistics

Range Today

1.47 1.62

Volume Today 20K

Range 1 Year

1.31 4.42

Volume 1 Year 78.01M

Range 3 Year

1.31 49.5

Volume 3 Year 136.18M

Range 10 Year

0.7 71.9

Volume 10 Year 148.62M

Highlights

Market Capitalization 3.8M (micro)

Floating Shares 1.98M

Current Price 1.49

Price To Earnings -0.92

Earnings Per Share -1.8

Payout Ratio 0%

Performance

Latest -2.61%

1 Month -21.16%

3 Months -27.32%

6 Months -39.18%

1 Year -49.83%

3 Years -91.34%

5 Years -85.1%

10 Years -69.59%

Benchmarks

Market Capitalization

356 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

184 / 368

Free Cashflow

52 / 352

Performance 5 years

251 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.